BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2014
View Archived Issues
Discovery of a bacterial class III lanthipeptide with antinociceptive properties
Read More
Fidarestat shows potential as an oral therapy for DME
Read More
PSMA MAb [177Lu]J-591 tested for treatment of metastatic solid tumors
Read More
TRK-170 attenuates chronic colitis in animal model
Read More
Epizyme begins pediatric proof-of-concept study of EPZ-5676
Read More
Pfizer reviews pipeline activities of first quarter 2014
Read More
AV Therapeutics to collaborate with consortium on phase I trials of capridine-beta
Read More
Cellmid selects lead anti-MK antibody in oncology
Read More
Hisamitsu Pharmaceutical reports data from phase II study of HP-3060
Read More
RaQualia enters into trial collaboration for RQ-00000010
Read More
Horizon Discovery licenses CRISPR/Cas9 gene editing technology from ERS Genomics
Read More
Novira Therapeutics begins phase Ia study of NVR-1221
Read More
Anti-miR-145 shows beneficial cardiac effect in models of pulmonary arterial hypertension
Read More
Results from phase I trial of XSpray's HyNap formulation of nilotinib
Read More
Synta reports results from final analysis of the GALAXY-1 trial
Read More
TG Therapeutics provides update on modified TGR-1202 formulation
Read More
Idera partners with Abbott on development of companion diagnostic for IMO-8400
Read More
Lundbeck to acquire Chelsea Therapeutics, including Northera
Read More
Lundbeck advances pipeline in first quarter 2014
Read More
NeoStem acquires California Stem Cell
Read More
DAV-132 could prevent the side effects of antibiotics on gut flora
Read More
FDA grants fast track status to Prima BioMed's CVac program
Read More
Amgen patents novel anti-IL-21R antibodies
Read More
Shanghai Institute Materia Medica discloses novel HSP90 inhibitors
Read More
MedImmune reports development of Abeta-binding antibodies
Read More
Novel aminoethyl nitrate compound shows safety and promising vasodilative activity in vivo
Read More
